These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP. Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932 [TBL] [Abstract][Full Text] [Related]
3. cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate. Voelkel NF; Allard JD; Anderson SM; Burke TJ J Appl Physiol (1985); 1999 May; 86(5):1715-20. PubMed ID: 10233139 [TBL] [Abstract][Full Text] [Related]
4. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine. Rahman MM; Varghese Z; Fuller BJ; Moorhead JF Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung. Iwabuchi S; Ono S; Tanita T; Koike K; Fujimura S Respiration; 1997; 64(1):54-8. PubMed ID: 9044476 [TBL] [Abstract][Full Text] [Related]
6. The effects of perfusion rate and NG-nitro-L-arginine methyl ester on cirazoline- and KCl-induced responses in the perfused mesenteric arterial bed of rats. Adeagbo AS; Tabrizchi R; Triggle CR Br J Pharmacol; 1994 Jan; 111(1):13-20. PubMed ID: 7912152 [TBL] [Abstract][Full Text] [Related]
7. Ischaemia--reperfusion injury in the rat is modulated by superoxide generation and leads to an augmentation of the hypoxic pulmonary vascular response. Messent M; Griffiths MJ; Quinlan GJ; Gutteridge JM; Evans TW Clin Sci (Lond); 1996 Jan; 90(1):47-54. PubMed ID: 8697705 [TBL] [Abstract][Full Text] [Related]
8. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. Weissmann N; Grimminger F; Voswinckel R; Conzen J; Seeger W Am J Physiol; 1998 May; 274(5):L721-7. PubMed ID: 9612287 [TBL] [Abstract][Full Text] [Related]
10. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Oka M; Hasunuma K; Webb SA; Stelzner TJ; Rodman DM; McMurtry IF Am J Physiol; 1993 Jun; 264(6 Pt 1):L587-97. PubMed ID: 8333550 [TBL] [Abstract][Full Text] [Related]
11. The cGMP pathway is not responsible for the blunted hypoxic vasoconstriction in rat lungs after altitude exposure. Asano K; Yanagidaira Y; Yoshimura K; Sakai A Acta Physiol Scand; 1997 Aug; 160(4):393-400. PubMed ID: 9338521 [TBL] [Abstract][Full Text] [Related]
12. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension. Liu YC; Kao SJ; Chuang IC; Chen HI Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs. Muramatsu M; Rodman DM; Oka M; McMurtry IF Am J Physiol; 1997 May; 272(5 Pt 1):L807-12. PubMed ID: 9176242 [TBL] [Abstract][Full Text] [Related]
15. Modulation of hypoxic pulmonary vasoconstriction by antioxidant enzymes in red blood cells. Yamaguchi K; Asano K; Takasugi T; Mori M; Fujita H; Oyamada Y; Suzuki K; Miyata A; Aoki T; Suzuki Y Am J Respir Crit Care Med; 1996 Jan; 153(1):211-7. PubMed ID: 8542118 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs. Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989 [TBL] [Abstract][Full Text] [Related]
17. TNF-alpha augments pulmonary vasoconstriction via the inhibition of nitrovasodilator activity. Johnson A; Ferro TJ J Appl Physiol (1985); 1992 Dec; 73(6):2483-92. PubMed ID: 1490962 [TBL] [Abstract][Full Text] [Related]
18. Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction. Byrne BM; Howard RB; Morrow RJ; Whiteley KJ; Adamson SL Placenta; 1997 Nov; 18(8):627-34. PubMed ID: 9364597 [TBL] [Abstract][Full Text] [Related]
19. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis. Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651 [TBL] [Abstract][Full Text] [Related]
20. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. Kurrek MM; Zapol WM; Holzmann A; Filippov G; Winkler M; Bloch KD Am J Physiol; 1995 Nov; 269(5 Pt 1):L618-24. PubMed ID: 7491980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]